Doctor profile · Federal record
Dr. David Parke, MD
Ophthalmology Physician (CMS: Ophthalmology) · Internal Medicine Physician · Ophthalmology Physician · Ophthalmology Physician · Minneapolis, MN
- NPI 1265638746
- Accepts Medicare
- MIPS 99.4 / 100 · 2023
- 19 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
7760 France Ave S, Suite 310
Minneapolis, MN 554355800
(952) 929-1131
fax (952) 897-1178
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- September 26, 2013
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (4)
- Minnesota #56678 · Oklahoma #25653 · Florida #TRN12604 · Florida #ME109699
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265638746. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
48,037
Distinct HCPCS
10
Medicare allowed
$6,071,792
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 33,300 | 94 | $36 | |
J0178 |
Injection, aflibercept, 1 mg | 4,240 | 414 | $868 | |
92134 |
Imaging of retina | 3,721 | 1,308 | $41 | |
67028 |
Injection of drug into eye | 2,762 | 687 | $131 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 1,251 | 77 | $232 | |
92012 |
Established patient problem focused exam of visual system | 863 | 536 | $91 | |
J9035 |
Injection, bevacizumab, 10 mg | 625 | 167 | $71 | |
92014 |
Established patient complete exam of visual system | 584 | 512 | $127 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 380 | 39 | $270 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 151 | 151 | $163 |
In context: peer comparison
Among 12 peers in Minneapolis Ophthalmology Physician, average services per provider: 547. This provider delivers 88× the peer median.Medicare Part D · 2023
Top prescriptions
Total claims
1,025
Patients
425
Total drug cost
$35,109
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 223 | 113 | $13,881 |
| Ketorolac Tromethamine | Generic | 212 | 59 | $5,714 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 121 | 107 | $1,826 |
| Latanoprost | Generic | 118 | 25 | $1,623 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 85 | 33 | $2,782 |
| Timolol Maleate | Generic | 53 | 19 | $618 |
| Atropine Sulfate | Generic | 51 | 26 | $2,660 |
| Brimonidine Tartrate | Generic | 51 | 17 | $785 |
| Dorzolamide Hcl | Generic | 42 | 0 | $1,139 |
| Dexamethasone Sodium Phosphate | Generic | 27 | 12 | $1,440 |
Frequently asked questions
What is Dr. David Parke's medical specialty?
Dr. David Parke practices Ophthalmology Physician in Minneapolis, MN.
Where does Dr. David Parke practice?
Dr. David Parke practices at 7760 France Ave S, Minneapolis, MN 554355800. Office phone: 9529291131.
What is Dr. David Parke's NPI?
Dr. David Parke's National Provider Identifier (NPI) is 1265638746, issued by NPPES.
Does Dr. David Parke accept Medicare assignment?
Yes. Dr. David Parke accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. David Parke commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, aflibercept, 1 mg (HCPCS J0178); Imaging of retina (HCPCS 92134). Source: CMS Medicare Physician & Other Practitioners file.